Effectiveness of oseltamivir in adults: A meta-analysis of published and unpublished clinical trials

Family Practice

Volumn 30, Issue 2, 2013, Pages 125-133

  Ebell, Mark H ^a   Call, Marlene ^a   Shinholser, JoAnna ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Hospitalization; Influenza; Meta analysis; Oseltamivir; Systematic review

Indexed keywords

ANTIBIOTIC AGENT; OSELTAMIVIR;

BRONCHITIS; CHRONIC DISEASE; DEHYDRATION; DISEASE DURATION; DRUG EFFICACY; HOSPITALIZATION; HUMAN; INFLUENZA; OTITIS MEDIA; PNEUMONIA; REVIEW; SEPSIS; SINUSITIS;

ADULT; ANTIVIRAL AGENTS; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; INTENTION TO TREAT ANALYSIS; MODELS, STATISTICAL; OSELTAMIVIR; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875580020     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cms059     Document Type: Review

References (23)

1. Jefferson T, Jones M, Doshi P, Del Mar C. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. BMJ 2009; 339: b5106.
2. Nicholson KG, Aoki FY, Osterhaus ADME et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000; 355: 1845-50.
3. Treanor JJ, Hayden FG, Vrooman PS et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA 2000; 283: 1016-24.
4. Linder JA, Nieva HR, Blumentals WA. Antiviral and antibiotic prescribing for influenza in primary care. J Gen Intern Med 2009; 24: 504-10.
5. Kaiser L, Wat C, Mills T et al. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003; 163: 1667-72.
6. Hernan MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis 2011; 53: 277-9.
7. Kashiwagi S, Kudoh S, Watanabe A, Yoshimura I. Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza-placebo-controlled double-blind multicenter phase III trial [in Japanese]. Kansenshogaku Zasshi 2000; 74: 1044-61.
8. Kolubukhina V. Efficacy of ozeltamivir (Tamiflu) in adult influenza on the epidemic rise of morbidity in Russia in the 2006-2007 season [article in Russian]. Voprosy virusologii 2008; 53 (4): 23-26.
9. Deng WW, Li QY, Zhong NS. "Oseltamivir in the treatment of suspected influenza patients" Study Group. A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients [in Chinese]. Zhonghua Yi Xue Za Zhi 2004; 84 2132-6.
10. Lin JT, Yu XZ, Cui DJ et al. A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population. Curr Med Res Opin 2006; 22 (1): 75-82.
11. Li L, A multicenter study of efficacy and safety of oseltamivir in treatment of naturally acquired influenza [in Chinese]. Chin J Int Med 2001; 40: 838-42.
12. Li L, Cai B, Wang M, Zhu Y. A double-blind, randomized, placebocontrolled multicenter study of oseltamivir phosphate for treatment of influenza infection in China. Chin Med J 2003; 116: 44-8.
13. Hopewell S, McDonald S, Clarke M, Egger M. Grey literature in meta-analyses of randomized trials of health care interventions. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: MR000010.
14. Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis KS. Withholding research results in academic life science: evidence from a national survey of faculty. JAMA 1997; 277: 1224-8.
15. Bodenheimer T. Uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342: 1539-44.
16. Egger M, Juni P, Bartlett C et al. How important are comprehensive literature searches and assessment of trial quality in systematic reviews? Empirical study. Health Technol Assesst 2003; 7: 1-76.
17. Gonzales R, Bartlett JG, Besser RE et al. for the American Academy of Family Physicians, American College of Physicians-American Society of Internal Medicine, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001; 134: 521-9.
18. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001; 134: 518-20.
19. Evans AT, Husain S, Durairaj L et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet 2002; 359: 1648-54.
20. Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
21. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167-70.
22. Singh S, Barghoorn J, Bagdonas A et al. Clinical benefits with oseltamivir in treating influenza in adult populations: results of a pooled and subgroup analysis. Clin Drug Investig 2003; 23: 561-9.
23. Falagas ME, Koletsi PK, Vouloumanou EK et al. Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010; 65: 1330-46.